Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser

London Vision Clinic150 enrolled

Overview

The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments. The EpiMaster application software is not used in this clinical investigation, consequently, it is a merely observational investigation.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Refractive Errors

Interventions

PTK-PRK refractive treatmentPROCEDURE

The PTK-PRK refractive treatment will be done according to routine clinical practice.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors * Patient present with myopic or myopic and astigmatic error * Patient will be able to understand the patient information and willing to sign an informed consent * Patient will be willing to comply with all follow-up visits and the respective examinations Exclusion Criteria: * Exclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors

Locations (2)

Pro Sight Eye Hospital

Chandigarh, Punjab Haryana, India

RECRUITING

Uma Eye Clinic

Chennai, Tamil Nadu, India

RECRUITING

Outcomes

Primary Outcomes

Difference of SE(measured) and SE(predicted by EpiMaster)

Percentage of eyes with SE6 months post-op "measured" - SEpredicted by EpiMaster within ±1.00D, with SE being the spherical equivalent

Time frame: 6 months

Central Contacts

Timothy Archer, PhD

CONTACT

+44 02072241005 timothy@londonvisionclinic.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.